Cancer Innovation Programme
The Cancer Innovation Programme supports QMUL researchers to explore how cancer research can be translated into real-world impact.
This programme is designed to build a stronger cancer innovation pipeline at QMUL by helping researchers, clinicians and students explore the translational, clinical and commercial potential of their ideas. Participants will gain exposure to founders and innovators, take part in practical cancer innovation workshops, connect with the wider innovation ecosystem through AMA sessions and mentoring, and receive support to develop promising ideas towards the next stage of validation, commercialisation or accelerator readiness. For selected projects, the programme will also provide tailored mentoring and guidance on potential applications to accelerators such as the Cancer Tech Accelerator (CTA).
You must be a PhD or researcher to be eligible for the programme.